Fig. 3From: Exploring the mechanism of the Fructus Mume and Rhizoma Coptidis herb pair intervention in Ulcerative Colitis from the perspective of inflammation and immunity based on systemic pharmacologyDocking diagram of core active components and core targets of FM-RC in the treatment of UC. (a) The ligand-receptor interaction screening of quercetin and MAPK1. (b) The ligand-receptor interaction screening of Palmidin A and PIK3CA. (c) The ligand-receptor interaction screening of kaempferol and PIK3CABack to article page